Anavex Life Sciences
AVXL
AVXL
143 hedge funds and large institutions have $164M invested in Anavex Life Sciences in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 53 increasing their positions, 46 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
7% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 14
20% less capital invested
Capital invested by funds: $206M → $164M (-$41.5M)
Holders
143
Holding in Top 10
–
Calls
$12.8M
Puts
$9.34M
Top Buyers
| 1 | +$3.48M | |
| 2 | +$3.11M | |
| 3 | +$1.76M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$948K |
| 5 |
BlackRock
New York
|
+$801K |
Top Sellers
| 1 | -$5.13M | |
| 2 | -$2.31M | |
| 3 | -$1.23M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$1.15M |
| 5 |
Goldman Sachs
New York
|
-$650K |